Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain
- Disease/Condition
- Pain
- Drug/Device/Intervention
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Icahn School of Medicine at Mount Sinai
- Location
- New York,New York,New York,New York, United States of America
- Phase
- N/A
- Start date
- Mar 18, 2024
- End date
- Feb 01, 2025
- Enrollment
- 98 participants
Pain Visual Analog Scale
This study is a double-blind, randomized, placebo-controlled trial to evaluate the use of
 high frequency TENS for pain control during IUD insertion. Transcutaneous electrical nerve
 stimulation (TENS) is a relatively low-cost, low-risk, non-pharmacologic intervention for
 pain management. Previous studies have found that TENS reduces pain associated with other
 outpatient gynecological procedures. Participants will be randomized in a 1:1 ratio to either
 active treatment or placebo (placebo TENS) and record pain scores using a 100 mm visual
 analog scale (VAS) at the time of IUD insertion. The same device will be used for both active
 and placebo treatment.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06245655
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06245655 through Pure Global AI's free database. This phase not specified trial is sponsored by Icahn School of Medicine at Mount Sinai and is currently Recruiting. The study focuses on Pain. Target enrollment is 98 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.